companydata.dkcompanydata.dk

CHR. OLESEN SYNTHESIS A/S: Financial statements 2014

CVR: 33964870

Source: annual report 2014, Danish Business Authority

01/10/2013 – 30/09/2014

CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2014. In 2014, the company reported a gross profit of EUR -165,799 and a net result of EUR -2,004,972 compared with EUR -1,455,185 the year before. Equity in the 2014 report amounted to EUR -4,625,081.

Gross Profit
EUR -165,799
Profit/Loss
EUR -2,004,972
Equity
EUR -4,625,081
Total Assets
EUR 4,889,367

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--166K EUR-2M EUR-4.6M EUR-
2013--85 EUR-1.5M EUR-2.6M EUR-
2012--934K-1.6M-1.2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

CHR. OLESEN SYNTHESIS A/S: The 2013 annual report is outFeb 27, 2014

CHR. OLESEN SYNTHESIS A/S has published its annual report for 2013. Gross profit came to DKK -85, and the net result was DKK -1,455,185.

About CHR. OLESEN SYNTHESIS A/S

CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.

Source: annual report 2025, Danish Business Authority